Onimaru Manabu, Inoue Haruhiro, Fujiyoshi Yusuke, Abad Mary Raina Angeli, Nishikawa Yohei, Toshimori Akiko, Shimamura Yuto, Tanabe Mayo, Sumi Kazuya, Ikeda Haruo
Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Endosc Int Open. 2021 Mar;9(3):E409-E416. doi: 10.1055/a-1333-1883. Epub 2021 Feb 19.
Since per-oral endoscopic myotomy (POEM) was introduced in 2010, it has become accepted as one of the standard treatments for esophageal achalasia worldwide. This study aimed to present long-term clinical results of POEM over 10 years and evaluate the technique and outcomes at the institution where it was first used in clinical settings. Questionnaire-based surveys were sent to patients who received POEM in our institution from September 2008 to May 2010. Patient demographics and procedural outcomes and open-ended questions were posed about the postoperative courses, including symptom improvement and recurrence, additional treatments, and post-POEM gastroesophageal reflux disease (GERD) symptoms. Achalasia symptoms and post-POEM GERD symptoms were evaluated with Eckhardt scores and GerdQ systems, respectively. Thirty-six consecutive POEMs were performed in that period and 10-year follow-up data were obtained from 15 patients (41.7 %). Although four cases (26.7 %) required additional pneumatic balloon dilatation (PBD), reduction in post-Eckardt scores were observed in 14 cases (93.3 %). GerdQ score was positive in one patient (6.7 %). Proton pump inhibitors (PPI) were taken by four patients (26.7 %) and their symptoms were well-controlled. Clinical results of POEM over 10 years were favorable regardless of various factors. Symptoms improved even in patients who required additional treatments, suggesting that POEM plays a significant role in treatment of achalasia.
自2010年经口内镜下肌切开术(POEM)问世以来,它已成为全球公认的食管贲门失弛缓症标准治疗方法之一。本研究旨在呈现POEM超过10年的长期临床结果,并评估其在首次应用于临床的机构中的技术及疗效。我们向2008年9月至2010年5月在本机构接受POEM治疗的患者发送了基于问卷的调查。调查涉及患者人口统计学信息、手术结果,并针对术后病程提出了开放式问题,包括症状改善和复发情况、额外治疗以及POEM术后胃食管反流病(GERD)症状。分别采用埃克哈特评分系统和GerdQ系统评估贲门失弛缓症症状和POEM术后GERD症状。在此期间共连续进行了36例POEM手术,从15例患者(41.7%)获得了10年的随访数据。尽管有4例(26.7%)患者需要额外进行气囊扩张术(PBD),但14例(93.3%)患者的埃克哈特评分有所降低。1例患者(6.7%)的GerdQ评分呈阳性。4例患者(26.7%)服用质子泵抑制剂(PPI),其症状得到良好控制。无论各种因素如何,POEM超过10年的临床结果良好。即使是需要额外治疗的患者,症状也有所改善,这表明POEM在贲门失弛缓症治疗中发挥着重要作用。